The authors focused on the folate receptor alpha (FRA), which is a glycosylphosphatidylinositol (GPI)-linked protein that is frequently overexpressed in various malignant tumors of epithelial origin, including ovarian, lung, and breast cancer, while largely absent from normal tissues. The gene discussed is FOLR1; the disease is breast carcinoma.